AT321459B - Verfahren zur Herstellung neuer Amidderivate von 7-Aminocephalosporinverbindungen - Google Patents

Verfahren zur Herstellung neuer Amidderivate von 7-Aminocephalosporinverbindungen

Info

Publication number
AT321459B
AT321459B AT15572A AT15572A AT321459B AT 321459 B AT321459 B AT 321459B AT 15572 A AT15572 A AT 15572A AT 15572 A AT15572 A AT 15572A AT 321459 B AT321459 B AT 321459B
Authority
AT
Austria
Prior art keywords
preparation
amide derivatives
new amide
aminocephalosporin
compounds
Prior art date
Application number
AT15572A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AT321459B publication Critical patent/AT321459B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT15572A 1971-01-11 1972-01-10 Verfahren zur Herstellung neuer Amidderivate von 7-Aminocephalosporinverbindungen AT321459B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10567371A 1971-01-11 1971-01-11

Publications (1)

Publication Number Publication Date
AT321459B true AT321459B (de) 1975-04-10

Family

ID=22307142

Family Applications (1)

Application Number Title Priority Date Filing Date
AT15572A AT321459B (de) 1971-01-11 1972-01-10 Verfahren zur Herstellung neuer Amidderivate von 7-Aminocephalosporinverbindungen

Country Status (16)

Country Link
AT (1) AT321459B (de)
AU (1) AU464424B2 (de)
BE (1) BE777580A (de)
CA (1) CA1006503A (de)
CH (1) CH582194A5 (de)
CS (1) CS179376B2 (de)
DE (1) DE2201074A1 (de)
ES (1) ES398734A1 (de)
FR (1) FR2121746B1 (de)
GB (1) GB1383431A (de)
HU (1) HU165335B (de)
IE (1) IE35973B1 (de)
IL (1) IL38508A (de)
NL (1) NL7200432A (de)
PL (1) PL87129B1 (de)
ZA (1) ZA718666B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941999B2 (ja) 1975-07-24 1984-10-11 武田薬品工業株式会社 セフエムまたはベナム化合物の製造法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL252433A (de) * 1959-06-09
US3173916A (en) * 1960-06-28 1965-03-16 Pfizer & Co C Derivatives of 7-aminocephalosporanic acid
US3144444A (en) * 1960-09-27 1964-08-11 Pfizer & Co C Novel derivatives of 6-aminopenicillanic acid
GB924612A (en) * 1960-12-19 1963-04-24 Ici Ltd Penicillins

Also Published As

Publication number Publication date
IE35973L (en) 1972-07-11
BE777580A (fr) 1972-06-30
NL7200432A (de) 1972-07-13
HU165335B (de) 1974-08-28
CH582194A5 (de) 1976-11-30
FR2121746B1 (de) 1974-12-13
GB1383431A (en) 1974-02-12
FR2121746A1 (de) 1972-08-25
AU3755572A (en) 1973-07-05
ES398734A1 (es) 1975-06-01
IL38508A0 (en) 1972-03-28
IL38508A (en) 1975-11-25
CA1006503A (en) 1977-03-08
AU464424B2 (en) 1975-08-28
CS179376B2 (en) 1977-10-31
ZA718666B (en) 1973-08-29
IE35973B1 (en) 1976-07-07
PL87129B1 (de) 1976-06-30
DE2201074A1 (de) 1972-08-03

Similar Documents

Publication Publication Date Title
AT308105B (de) Verfahren zur Herstellung von Dibenzylaminofluoranverbindungen
AT319249B (de) Verfahren zur Herstellung neuer Chinolinderivate
AT314729B (de) Verfahren zur Herstellung von neuen 3-Hydroxy-3-methylcephamverbindungen
AT306251B (de) Verfahren zur Herstellung von neuer N(6)-Aralkyl-adenosin-Derivate
AT319259B (de) Verfahren zur Herstellung neuer Dihydropyridazone
AT304541B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT315837B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT316510B (de) Verfahren zur Herstellung von neuen Diphenylaminverbindungen
AT323736B (de) Verfahren zur herstellung neuer 2-nitroimidazolderivate
CH543479A (de) Verfahren zur Herstellung von Phenyläthylaminderivaten
AT320641B (de) Verfahren zur Herstellung von Oxazolinen
ATA221172A (de) Verfahren zur herstellung neuer 2-hydroxybenzophenonderivate
AT339894B (de) Verfahren zur herstellung neuer pyrazoliumsalze
AT306922B (de) Verfahren zur Herstellung von Erythromycylaminverbindungen
AT306235B (de) Verfahren zur Herstellung von Erythromycylaminverbindungen
AT326816B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinverbindungen
AT321459B (de) Verfahren zur Herstellung neuer Amidderivate von 7-Aminocephalosporinverbindungen
AT339286B (de) Verfahren zur herstellung von n-(diathylaminoathyl)-2-methoxy-4-amino-5-chlorbenzamid
AT308103B (de) Verfahren zur Herstellung von neuen Tetrazol-Anthrachinonverbindungen
AT303257B (de) Verfahren zur Herstellung von neuen Acylaminoverbindungen
AT311339B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT305301B (de) Verfahren zur Herstellung von neuen 6-Chlorpyridaziniumverbindungen
AT323721B (de) Verfahren zur herstellung neuer 4-(4-biphenylyl)-4-oxo-buttersäureamide
AT337168B (de) Verfahren zur herstellung neuer fluorenonderivate
AT342028B (de) Verfahren zur herstellung neuer chloracetanilide

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee